{
    "id": "dbpedia_2609_0",
    "rank": 70,
    "data": {
        "url": "https://www.groupbstrepinternational.org/gbs-medical-articles-and-abstracts.html",
        "read_more_link": "",
        "language": "en",
        "title": "GBS Medical Articles and Abstracts",
        "top_image": "https://www.groupbstrepinternational.org/uploads/9/9/9/4/99946050/published/gbs-research-logo-transparent.png?1700237937",
        "meta_img": "https://www.groupbstrepinternational.org/uploads/9/9/9/4/99946050/published/gbs-research-logo-transparent.png?1700237937",
        "images": [
            "https://www.groupbstrepinternational.org/uploads/9/9/9/4/99946050/published/logo.png?1486206356",
            "https://www.groupbstrepinternational.org/uploads/9/9/9/4/99946050/published/gbs-research-logo-transparent.png?1700237937"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            "medical article",
            "medical abstracts",
            "pathology",
            "one health",
            "preterm birth",
            "fetal movement",
            "clinical trials",
            "vaccine",
            "serotypes",
            "group B strep research",
            "researcher",
            "iGBS",
            "invasive group B strep disease",
            "what is group B strep",
            "What is GBS",
            "Group B strep",
            "Str"
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "A comprehensive list of GBS medical articles and abstracts.",
        "meta_lang": "en",
        "meta_favicon": "",
        "meta_site_name": "Group B Strep International",
        "canonical_link": "https://www.groupbstrepinternational.org/gbs-medical-articles-and-abstracts.html",
        "text": "Breastfeeding Tied to Big Reduction in Infant Deaths\n\nHealthDay, August 2, 2023\n\nAssociations Between Breastfeeding and Post-perinatal Infant Deaths in the U.S.\n\nJulie L Ware et al. American Journal of Preventative Medicine, May 21, 2023.\n\n​\n\nBreastfeeding as a Tool that Empowers Infant Immunity Through Maternal Vaccination\n\nSaad Musbah Alasil and Prameela Kannan Kutty. 16 February 2015. Journal of Vaccines & Vaccination 2015, 6:2\n\nHuman breast milk: A review on its composition and bioactivity\n\nAndreas NJ, Kampmann B, Mehring Le-Doare K. Early Hum Dev. 2015 Nov;91(11):629-35. doi: 10.1016/j.earlhumdev.2015.08.013. Epub 2015 Sep 12. PMID: 26375355.\n\nMother’s Milk Still Best-and We Must Do Better. (abstract)\n\nSarasa, NL. MEDICC Rev. 2013 Jan;15(1):48.\n\nThe human milk microbiota: origin and potential roles in health and disease.\n\nFernández L, Langa S, Martín V, Maldonado A, Jiménez E, Martín R, Rodríguez JM. Pharmacol Res. 2013 Mar;69(1):1-10. doi: 10.1016/j.phrs.2012.09.001. Epub 2012 Sep 10.\n\nBreastfeeding and the Use of Human Milk\n\nAmerican Academy of Pediatrics Policy Statement\n\nPediatrics Vol. 129 No. 3 March 1, 2012, pp e827-e841 (doi: 10.1542/peds.2011-3552)\n\nThe Surgeon General's Call to Action to Support Breastfeeding.\n\nSurgeonGeneral.gov. 20 Jan. 2011.\n\nBreastfeeding Provides Passive and Likely Long-Lasting Active Immunity\n\nLars A Hanson, Annals of Allergy, Asthma & Immunology. Volume 81, Issue 6, December 1998, Pages 523-534, 537\n\nIsotype composition of antibodies to streptococcus group B type III polysaccharide and to tetanus toxoid in maternal, cord blood sera and in breast milk (abstract)\n\nLagergard T, Thiringer K, Wassen L, Schneerson R, Trollfors B., Department of Medical Microbiology, University of Goteborg, Sweden. Eur J Pediatr. 1992 Feb;151(2):98-102.\n\n​\n\nImmunoglobulin concentrations and bacterial antibody titres in breast milk from mothers of ‘preterm’ and ‘term’ infants (abstract)\n\nSuzuki S, Lucas A, Lucas PJ, Coombs RR. Acta Paediatr Scand. 1983 Sep;72(5):671-7.\n\nBreastfeeding and Risk of Late-Onset Group B Streptococcal Disease.\n\nChing NS, Buttery JP, Lai E, Steer AC, Standish J, Ziffer J, Daley AJ, Doherty R. Pediatrics. 2021 Sep;148(3):e2020049561. doi: 10.1542/peds.2020-049561. Epub 2021 Aug 12. PMID: 34385351.\n\nGroup B streptococcus late-onset disease, contaminated breast milk and mothers persistently GBS negative: report of 3 cases\n\nNicolini, G., Borellini, M., Loizzo, V., Creti, R., Memo, L., & Berardi, A. (2018). BMC pediatrics, 18(1), 214. https://doi.org/10.1186/s12887-018-1192-x\n\nLate-onset neonatal group B streptococcal disease associated with breast milk transmission: molecular typing using RAPD-PCR.\n\nBrandolini M., Corbella M., Cambieri P., et al. Early Hum Dev. 2014 Mar; 90 Suppl 1:S84-6.\n\nBreast milk and Group B streptococcal infection: vector of transmission or vehicle for protection?\n\nLe Doare K, Kampmann B.\n\nVaccine. 2014 May 30;32(26):3128-32. doi: 10.1016/j.vaccine.2014.04.020. Epub 2014 Apr 13.\n\nGroup B Streptococcus Late-Onset Disease: 2003–2010. (here in .pdf format: )\n\nBerardi A, Rossi C, Lugli L, Creti R, et al. Pediatrics. February 2013/Issue 2.\n\nGroup B streptococcal colonization in 160 mother-baby pairs: a prospective cohort study. (abstract)\n\nBerardi A, Rossi C, Creti R, China M, Gherardi G, Venturelli C, Rumpianesi F, Ferrari F.\n\nJ Pediatr. 2013 Oct;163(4):1099-104.e1. doi: 10.1016/j.jpeds.2013.05.064. Epub 2013 Jul 15.\n\nGroup B streptococcus colonization of breast milk of group B streptococcus positive mothers. (abstract)\n\nBurianová I, Paulová M, Cermák P, Janota J.\n\nJ Hum Lact. 2013 Nov;29(4):586-90. doi: 10.1177/0890334413479448. Epub 2013 Mar 22.\n\n​\n\nTo feed or not to feed? Case presentation and best practice guidance for human milk feeding and group B streptococcus in developed countries. (abstract)\n\nDavanzo R, De Cunto A, Travan L, Bacolla G, Creti R, Demarini S.\n\nJ Hum Lact. 2013 Nov;29(4):452-7. doi: 10.1177/0890334413480427. Epub 2013 Mar 18.\n\nLate-onset group B streptococcal disease by infected mother’s milk detected by polymerase chain reaction. (abstract) (.pdf version)\n\nLanari M, Serra L, Cavrini F, Liguori G, Sambri V.,Department of Paediatrics, Santa Maria della Scaletta Hospital, Imola, Italy. New Microbiol. 2007 Jul;30(3):253-4.\n\nRecurrent neonatal group B streptococcal disease associated with infected breast milk.\n\nWang LY, Chen CT, Liu WH, Wang YH. Clin Pediatr (Phila). 2007 Jul;46(6):547-9.\n\n​\n\nNeonatal group B streptococcal infection related to breast milk. (abstract with link to full text as a PDF)\n\nByrne PA, Miller C, Justus K, Department of Pediatrics and Neonatology, Saint Charles Mercy Hospital, Oregon, Ohio 43616, USA. [email protected] <[email protected]> Breastfed Med, 2006 Winter;1(4):263-70.\n\nLate-onset and recurrent neonatal Group B streptococcal disease associated with breast-milk transmission. (abstract)\n\nKotiw M, Zhang GW, Daggard G, Reiss-Levy E, Tapsall JW, Numa A, Center for Biomedical Research, Department of Biological and Physical Sciences, Faculty of Sciences, University of Southern Queensland, Toowoomba, Queensland, Australia 4350. [email protected]. Pediatr Dev Pathol. 2003 May-Jun;6(3):251-6. Epub 2003 Apr 14.\n\nBreast milk transmission of group B streptococcal infection. (abstract)\n\nDinger J, Müller D, Pargac N, Schwarze R., Clinic of Pediatrics, Medical Faculty, Technical University of Dresden, Germany. [email protected] Pediatr Infect Dis J. 2002 Jun;21(6):567-8.Source\n\nNeonatal group B streptococcal disease associated with infected breast milk.\n\nOlvera WJ., Bondb DW., Boswellc TC., et al. Archives of Disease in Childhood - Fetal and Neonatal Edition. 2000; 83:F48-F49.\n\nCANADA\n\n​\n\nEstimating the Burden of Infant Group B Streptococcus Disease in Ontario, Canada: a Population-Based Cohort Study\n\nFakhraei R, El-Chaar D, Sander B, Thampi N, Brown K, Fell D. (2024) American Journal of Obstetrics and Gynecology. VOLUME 230, ISSUE 2, SUPPLEMENT , S640, FEBRUARY 2024. DOI:https://doi.org/10.1016/j.ajog.2023.09.059\n\nGroup B Streptococcal Infections in Newborns\n\nHealthwise Staff , May 4, 2017\n\nEpidemiology of early-onset neonatal group B streptococcal infection: implications for screening\n\nKonrad, G., & Katz, A. (2007). Canadian family physician Medecin de famille canadien, 53(6), e.1–1054.\n\nBRAZIL\n\nChanges in Group B Streptococcus Colonization among Pregnant Women before and after the Onset of the COVID-19 Pandemic in Brazil\n\nCosta, N. S., Rio-Tinto, A., Pinto, I. B. F., Dos Santos Silva Alvim, D. C., de Assis Rocha, A., Oliveira, L. M. A., Botelho, A. C. N., Fracalanzza, S. E. L., Teixeira, L. M., Rezende-Filho, J., Marinho, P. S., Amim Júnior, J., Taylor, S., Thomas, S., & Pinto, T. C. A. (2022). Pathogens (Basel, Switzerland), 11(10), 1104. https://doi.org/10.3390/pathogens11101104\n\nEarly-onset neonatal sepsis by Group B Streptococcus in a Brazilian public hospital\n\nBarbosa NG, Dos Reis H, Mantese OC, Mussi-Pinhata MM, Abdallah VO, Gontijo Filho PP. Braz J Infect Dis. 2016 Nov-Dec;20(6):647-648. doi: 10.1016/j.bjid.2016.07.013. Epub 2016 Aug 24. PMID: 27565421; PMCID: PMC9427652.\n\nDOMINICAN REPUBLIC\n\nNear-term pregnant women in the Dominican Republic experience high rates of Group B Streptococcus rectovaginal colonization with virulent strains\n\nLaycock, K. M., Acosta, F., Valera, S., Villegas, A., Mejia, E., Mateo, C., Felipe, R., Fernández, A., Job, M., Dongas, S., Steenhoff, A. P., Ratner, A. J., & Geoghegan, S. (2023). PLOS global public health, 3(9), e0002281. https://doi.org/10.1371/journal.pgph.0002281\n\nMEXICO\n\nGenomic analysis of virulence factors and antimicrobial resistance of group B Streptococcus isolated from pregnant women in northeastern Mexico\n\nPalacios-Saucedo, G. D. C., Rivera-Morales, L. G., Vázquez-Guillén, J. M., Caballero-Trejo, A., Mellado-García, M. C., Flores-Flores, A. S., González-Navarro, J. A., Herrera-Rivera, C. G., Osuna-Rosales, L. E., Hernández-González, J. A., Vázquez-Juárez, R., Barrón-Enríquez, C., Valladares-Trujillo, R., Treviño-Baez, J. D., Alonso-Téllez, C. A., Ramírez-Calvillo, L. D., Cerda-Flores, R. M., Ortiz-López, R., Rivera-Alvarado, M. Á., Solórzano-Santos, F., … Rodríguez-Padilla, C. (2022). PloS one, 17(3), e0264273. https://doi.org/10.1371/journal.pone.0264273\n\n[Group B streptococcal perinatal infection: A Global, Latin American and Mexican Overview]\n\nPalacios-Saucedo, G. C., Hernández-Hernández, T. I., Rivera-Morales, L. G., Briones-Lara, E., Caballero-Trejo, A., Vázquez-Guillén, J. M., Amador-Patiño, G. I., García-Cabello, R., Solórzano-Santos, F., & Rodríguez-Padillacs, C. (2017). Infección perinatal por estreptococo del grupo B: panorama global, en América Latina y en México. Gaceta medica de Mexico, 153(3), 361–370.\n\nNICARAGUA\n\n​\n\nRectovaginal Colonization with Serotypes of Group B Streptococci with Reduced Penicillin Susceptibility among Pregnant Women in León, Nicaragua\n\nAlemán T, Vielot NA, Herrera R, et al. Pathogens. 2022;11(4):415. Published 2022 Mar 29. doi:10.3390/pathogens11040415\n\n​TRINIDAD\n\n​\n\nAntimicrobial susceptibility patterns of group B Streptococci isolated from pregnant women in Trinidad, West Indies.\n\nOrrett FA. Saudi Med J. 2004 Nov;25(11):1764-5. No abstract available.\n\n​Colonization with Group B streptococci in pregnancy and outcome of infected neonates in Trinidad.\n\nOrrett FA. Pediatr Int. 2003. Jun; 45(3): 319-23.\n\n​\n\nPrevalence of group B streptococcal colonization in pregnant third trimester women in Trinidad.\n\nOrrett FA, Olagundoye V. J Hosp Infect. 1994 May;27(1):43-8.\n\nEarly-onset group B streptococcal disease in African countries and maternal vaccination strategies\n\nDangor, Z., Seale, A. C., Baba, V., & Kwatra, G. (2023). Frontiers in public health, 11, 1214844. https://doi.org/10.3389/fpubh.2023.1214844\n\nMaternity care provider acceptance of a future Group B Streptococcus vaccine - A qualitative study in three countries​\n\nSarah Geoghegan, Francia Acosta, Laura C Stephens, Hanah Gillan, Sandra Valera, Richard J Drew, Maeve Eogan, Adam J Ratner, Andrew P Steenhoff, Karina M Butler, Kristen A Feemster. Vaccine. 2023 Mar 17;41(12):2013-2021. doi: 10.1016/j.vaccine.2023.02.037.Epub 2023 Feb 18.\n\n​Neonatal invasive disease caused by Streptococcus agalactiae in Europe: the DEVANI multi-center study\n\nLohrmann, F., Hufnagel, M., Kunze, M. et al. Infection (2022).\n\n​\n\nGroup B streptococcus infection during pregnancy and infancy: estimates of regional and global burden\n\nBronner P Gonçalves, MD, Simon R Procter, DPhil, Proma Paul, DrPH, Jaya Chandna, MSc, Alexandra Lewin, PhD, Farah Seedat, PhD, et al. The Lancet. VOLUME 10, ISSUE 6, E807-E819, JUNE 01, 2022\n\nPublished:April 28, 2022 DOI:https://doi.org/10.1016/S2214-109X(22)00093-6\n\nNeurodevelopmental and growth outcomes after invasive Group B Streptococcus in early infancy: A multi-country matched cohort study in South Africa, Mozambique, India, Kenya, and Argentina\n\n28 April 2022, 101358\n\nDifferences in maternal group B Streptococcus screening rates in Latin American countries\n\nHogenEsch, E., De Mucio, B., Haddad, L. B., Vilajeliu, A., Ropero, A. M., Yildirim, I., & Omer, S. B. (2021). Vaccine, 39 Suppl 2, B3–B11. https://doi.org/10.1016/j.vaccine.2020.10.082\n\nGroup B Streptococcal Colonization in African Countries: Prevalence, Capsular Serotypes, and Molecular Sequence Types\n\nShabayek S, Ferrieri P, Spellerberg B. Pathogens. 2021; 10(12):1606. https://doi.org/10.3390/pathogens10121606\n\n[Group B streptococcal perinatal infection: A Global, Latin American and Mexican Overview]\n\nPalacios-Saucedo, G. C., Hernández-Hernández, T. I., Rivera-Morales, L. G., Briones-Lara, E., Caballero-Trejo, A., Vázquez-Guillén, J. M., Amador-Patiño, G. I., García-Cabello, R., Solórzano-Santos, F., & Rodríguez-Padillacs, C. (2017). Infección perinatal por estreptococo del grupo B: panorama global, en América Latina y en México. Gaceta medica de Mexico, 153(3), 361–370.\n\n​Intrapartum Antibiotic Chemoprophylaxis Policies for the Prevention of Group B Streptococcal Disease Worldwide: Systematic Review\n\nLe Doare, K., O'Driscoll, M., Turner, K., Seedat, F., Russell, N. J., Seale, A. C., Heath, P. T., Lawn, J. E., Baker, C. J., Bartlett, L., Cutland, C., Gravett, M. G., Ip, M., Madhi, S. A., Rubens, C. E., Saha, S. K., Schrag, S., Sobanjo-Ter Meulen, A., Vekemans, J., Kampmann, B., … GBS Intrapartum Antibiotic Investigator Group (2017). Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 65(suppl_2), S143–S151. https://doi.org/10.1093/cid/cix654\n\nIncidence and serotype distribution of invasive group B streptococcal disease in young infants: a multi-country observational study\n\nRivera, L., Sáez-Llorens, X., Feris-Iglesias, J., Ip, M., Saha, S., Adrian, P. V., … Slobod, K. S. (2015). Incidence and serotype distribution of invasive group B streptococcal disease in young infants: a multi-country observational study. BMC Pediatrics, 15, 143. http://doi.org/10.1186/s12887-015-0460-2\n\nStillbirth With Group B Streptococcus Disease Worldwide: Systematic Review and Meta-analyses\n\nAnna C Seale, Hannah Blencowe, Fiorella Bianchi-Jassir, Nicholas Embleton,et al; Stillbirth With Group B Streptococcus Disease Worldwide: Systematic Review and Meta-analyses, Clinical Infectious Diseases, Volume 65, Issue suppl_2, 6 November 2017, Pages S125–S132. ​\n\nGroup B streptococcus infection during pregnancy and infancy: estimates of regional and global burden\n\nGonçalves, BP, Procter, SR, Paul, P., Chandna, J., Lewin, A., Seedat, F., Koukounari, A., Dangor, Z., Leahy, S., Santhanam, S., John, HB, Bramugy, J., Bardají, A., Abubakar, A., Nasambu, C., Libster, R., Sánchez Yanotti, C. , Horváth-Puhó, E. , Sørensen, HT , ... CHAMPS team ( 2022). The Lancet Global Health , 10 (6), e807-e819. https://doi.org/10.1016/S2214-109X(22)00093-6\n\nEstimates of the Burden of Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children. Seale AC, Bianchi-Jassir F, Russell NJ, Kohli-Lynch M, Tann CJ, Hall J, Madrid L, Blencowe H, Cousens S, Baker CJ, Bartlett L, Cutland C, Gravett MG, Heath PT, Ip M, Le Doare K, Madhi SA, Rubens CE, Saha SK, Schrag SJ, Sobanjo-Ter Meulen A, Vekemans J, Lawn JE. Clin Infect Dis. 2017 Nov 6;65(suppl_2):S200-S219.\n\nGroup B streptococcus incidence rises significantly among newborns despite widespread adoption of prevention initiatives.\n\nThe Lancet. “Group B streptococcus incidence rises significantly among newborns despite widespread adoption of prevention initiatives.” ScienceDaily. ScienceDaily, 20 October 2014. <www.sciencedaily.com/releases/2014/10/141020090138.htm>.\n\n“Group B streptococcus, a major cause of serious infectious diseases including sepsis, meningitis, and pneumonia, has increased by about 60% among infants younger than 3 months in the Netherlands over the past 25 years despite the widespread use of prevention strategies, new research has found.”\n\n​Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis (abstract)\n\nDr Karen M Edmond PhD, Christina Kortsalioudaki MBBS, Susana Scott PhD, Stephanie J Schrag DPhil, Prof Anita KM, Zaidi MBBS, Prof Simon Cousens DipMathStat, Prof Paul T Heath MBBS [Hons].\n\nThe Lancet, Volume 379, Issue 9815, Pages 547 -556, 11 February 2012, doi:10.1016/S0140-6736(11)61651-6.\n\n“Despite widespread use of intrapartum antibiotic prophylaxis, group B streptococcus remains a leading cause of morbidity and mortality in infants in Europe, the Americas, and Australia. However, estimates of disease burden in many countries outside of these regions is not available. We aimed to examine the current global burden of invasive disease and the serotype distribution of group B streptococcus isolates.”\n\nEvaluation of Universal Antenatal Screening for Group B Streptococcus\n\nVan Dyke et al. The New England Journal of Medicine 2009; 360:2626-2636 June 18, 2009\n\nThis paper analyzes the implementation and impact of the universal screening recommendations on provider methods and the incidence of GBS disease. It highlights the positive impact of universal screening and also identifies areas that need continued improvement.\n\nPerinatal Group B Streptococcal Disease After Universal Screening Recommendations; United States, 2003-2005\n\nCDC MMWR Weekly, July 20, 2007. “…Although incidence among white infants decreased steadily during 2003–2005, incidence increased 70% among black infants.”\n\nGroup B streptococcal disease in UK and Irish infants younger than 90 days. (abstract)\n\nHeath PT et al. Lancet. 2004 Jan 24;363(9405):292-4.\n\nGENERAL\n\nThe urgent need to recognize and properly address prenatal-onset group B Streptococcus disease​\n\nNatália Silva Costa, Laura Maria Andrade Oliveira, Tomislav Meštrović, Christina W. Obiero, Shui Shan Lee, Tatiana Castro Abreu Pinto. Published:October 12, 2022. VOLUME 124, P168-170, DOI:https://doi.org/10.1016/j.ijid.2022.10.016\n\nGroup B streptococcal infections during pregnancy and perinatal consequences: what do we need to determine more than a bacteriological analysis?\n\nAnca A. Simionescu, Ana Maria Alexandra Stanescu. Ref: Ro J Infect Dis. 2021;24(2) DOI: 10.37897/RJID.2021.2.2\n\n​Study Shows How Group B Strep Establishes In Utero Infection, Posing Risk to Baby\n\nLindsay Kurs (2018). Seattle Children's Hospital ​\n\n​Maternal group B Streptococcus recto vaginal colonization increases the odds of stillbirth: evidence from Eastern Ethiopia\n\nYadeta, T.A., Worku, A., Egata, G. et al. BMC Pregnancy Childbirth18, 410 (2018). https://doi.org/10.1186/s12884-018-2044-2\n\nStillbirth With Group B Streptococcus Disease Worldwide: Systematic Review and Meta-analyses\n\nSeale, A. C., Blencowe, H., Bianchi-Jassir, F., Embleton, N., Bassat, Q., Ordi, J., Menéndez, C., Cutland, C., Briner, C., Berkley, J. A., Lawn, J. E., Baker, C. J., Bartlett, L., Gravett, M. G., Heath, P. T., Ip, M., Le Doare, K., Rubens, C. E., Saha, S. K., Schrag, S., … Madhi, S. A. (2017). Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 65(suppl_2), S125–S132. https://doi.org/10.1093/cid/cix585\n\nThe role of infection in miscarriage\n\nGiakoumelou, S., Wheelhouse, N., Cuschieri, K., Entrican, G., Howie, S. E., & Horne, A. W. (2016). Human reproduction update, 22(1), 116–133. https://doi.org/10.1093/humupd/dmv041\n\nA streptococcal lipid toxin induces membrane permeabilization and pyroptosis leading to fetal injury.\n\n​Whidbey C, Vornhagen J, Gendrin C, et al. EMBO Mol Med. 2015 Apr;7(4):488-505.\n\n​​\n\nIntrapartum evidence of early-onset group B streptococcus.\n\nTudela CM, Stewart RD, Roberts SW, Wendel GD Jr, Stafford IA, McIntire DD, Sheffield JS.\n\nObstet Gynecol. 2012 Mar;119(3):626-9. doi: 10.1097/AOG.0b013e31824532f6.\n\n“We believe that these findings are compelling evidence that fetuses with early-onset GBS may have signs of sepsis peripartum. We hypothesize that these data support the concept that early-onset GBS represents a spectrum of infection that often precedes birth.”​\n\n​Intrauterine infection may be a major cause of stillbirth in Sweden\n\nEgle Tolockiene, Eva Morsing, Elisabeth Holst , Andreas Herbst, Åsa Ljungh, Nils Svenningsen, Inga Hägerstrand, Lennarth Nyström First published: 03 July 2003. Volume80, Issue6, Pages 511-518 DOI: https://doi.org/10.1034/j.1600-0412.2001.d01-151.x\n\nIntrauterine infections with group B beta-haemolytic streptococci\n\nDesa DJ, Trevenen CL. Br J Obstet Gynaecol. 1984 Mar;91(3):237-9. doi: 10.1111/j.1471-0528.1984.tb04759.x. PMID: 6367810.\n\nAntibiotic Management of Miscarriages Associated with Group B Streptococcus Genital Tract Infection\n\n​Attila Toth, MD. Clinical Associate Professor, New York Hospital – Presbyterian Medical Center. Case Reports.\n\n​​\n\nASCENDING INFECTION\n\n​Bacterial and Host Determinants of Group B Streptococcal Vaginal Colonization and Ascending Infection in Pregnancy\n\nAlyssa Brokaw, Anna Furuta, Matthew Dacanay, Lakshmi Rajagopal, and Kristina M. Adams Waldorf. Front. Cell. Infect. Microbiol., 03 September 2021 | https://doi.org/10.3389/fcimb.2021.720789\n\nBacterial Hyaluronidase Promotes Ascending GBS Infection and Preterm Birth\n\nVornhagen, J., Quach, P., Boldenow, E., Merillat, S., Whidbey, C., Ngo, L. Y., Adams Waldorf, K. M., & Rajagopal, L. (2016). mBio, 7(3), e00781-16. https://doi.org/10.1128/mBio.00781-16\n\n​\n\nCHORIOAMNIONITIS\n\nAssociation between group B streptococcus positivity and maternal infectious morbidity\n\nJennifer A. McCoy, Kira A. Bromwich, Kristin D. Gerson, Lisa D. Levine. VOLUME 228, ISSUE 1, SUPPLEMENT , S490-S491, JANUARY 2023 DOI:https://doi.org/10.1016/j.ajog.2022.11.844\n\n​Genome-Wide fitness analysis of group B Streptococcus in human amniotic fluid reveals a transcription factor that controls multiple virulence traits\n\nAllison N. Dammann, Anna B. Chamby, Andrew J. Catomeris, Kyle M. Davidson, Hervé Tettelin, Jan-Peter van Pijkeren, Kathyayini P. Gopalakrishna, Mary F. Keith, Jordan L. Elder, Adam J. Ratner, Thomas A. Hooven. Version 2 March 8, 2021 https://doi.org/10.1371/journal.ppat.1009116\n\n(Maternal Fever) Diagnosis and Management of Clinical Chorioamnionitis\n\n​Tita A. T. N, Andrews W. W. Clin Perinatol. 2010 Jun; 37(2): 339-354.\n\n​Peripartum infection associated with vaginal group B streptococcal colonization.\n\nYancey MK, Duff P, Clark P, Kurtzer T, Frentzen BH, Kubilis P. Obstet Gynecol. 1994 Nov;84(5):816-9.\n\n“Intrapartum vaginal colonization with group B streptococci is an important independent risk factor for chorioamnionitis.”\n\nGroup B streptococcus amnionitis with intact membranes associated with quintuplet delivery\n\n​Neri A., Wielunsky E., Henig E., et al. European Journal of Obstetrics &Gynecology and Reproductive Biology. Volume 17, Issue 1, April 1984, Pages 29-32.\n\nPreterm Birth Associated With Group B Streptococcus Maternal Colonization Worldwide: Systematic Review and Meta-analyses\n\nF. Bianchi-Jassir, A. C Seale, M. Kohli-Lynch, J. E Lawn, C. J Baker, L. Bartlett, et al. Clinical Infectious Diseases, Volume 65, Issue suppl_2, 6 November 2017, Pages S133–S142,\n\n​Bacterial Hyaluronidase Promotes Ascending GBS Infection and Preterm Birth\n\nJay Vornhagen, Phoenicia Quach, Erica Boldenow, Sean Merillat, Christopher Whidbey, Lisa Y. Ngo, K. M. Adams Waldorf, Lakshmi Rajagopal. mBio Jun 2016, 7 (3) e00781-16; DOI: 10.1128/mBio.00781-16\n\nMembrane Vesicles of Group B Streptococcus Disrupt Feto-Maternal Barrier Leading to Preterm Birth\n\nVishnu Surve M, Anil A, Ganesh Kamath K, et al. PLOS Pathogens. 1, Sep. 2016.\n\n​Genetic risk factor for premature birth found.\n\nUniversity of California, San Diego Health Sciences. ScienceDaily. ScienceDaily, 6 May 2014.\n\n“Researchers have discovered a genetic risk factor for premature birth. The risk factor is related to a gene that codes for a protein that the scientists have found helps the body’s immune cells recognize and fight Group B Streptococcus (GBS) bacteria. These bacteria are found in the vagina or lower gastrointestinal tract of approximately 15 to 20 percent of healthy women, but may cause life-threatening infections, such as sepsis or meningitis in newborns, especially those born prematurely.”\n\nA hemolytic pigment of Group B Streptococcus allows bacterial penetration of human placenta. (abstract)\n\nWhidbey C et al. J Exp Med. 2013 Jun 3;210(6):1265-81. doi: 10.1084/jem.20122753. Epub 2013 May 27.\n\nThe Contribution of Maternal Stress to Preterm Birth: Issues and Considerations\n\nWadhwa, P. D., Entringer, S., Buss, C., & Lu, M. C. (2011). The Contribution of Maternal Stress to Preterm Birth: Issues and Considerations. Clinics in Perinatology, 38(3), 351–384. http://doi.org/10.1016/j.clp.2011.06.007\n\nIntra-Uterine Death Due To B-Haemolytic Streptococcus Despite Intact Membranes.\n\nD D'Souza, A Sharma. The Internet Journal of Gynecology and Obstetrics. 2007 Volume 10 Number 1.\n\n​Prevention of Group B Streptococcal Disease in the Newborn\n\nBS Apgar, MD, MS; G Greenberg, MD, MA; and G YEN, MD American Family Physician, March 1 2005\n\n“Compared with infants born to lightly colonized women, those born to heavily colonized women have 2.5 times the risk of infection. Neonates born to mothers who have GBS bacteriuria at any time during pregnancy are known to be more frequently and more heavily colonized with GBS and are more likely to develop sepsis. Infections that occur in the first two days of life usually are caused by exposure to maternal organisms. Risk factors for neonatal transmission and infection are listed in Table 1. Compared with term newborns, preterm and low-birth-weight infants have increased rates of GBS sepsis.”\n\n​Is there a correlation between the vaginal colonization with group B streptococci and premature deliveries? (abstract)\n\nKovachev E, Markova V, Bozhkova K, Popova A, Tsvetkova S, Cherneva S. Akush Ginekol (Sofiia). 2003;42 Suppl 2:3-5.\n\n​Premature labor with intact membranes: microbiology of the amniotic fluid and lower genital tract and its relation with maternal and neonatal outcome. (abstract)\n\nRev Med Chil. 2000 Sep;128(9):985-95. Ovalle A, Martinez MA, Gomez R, Saez J, Menares I, Aspillaga C, Schwarze JE.\n\n“In preterm labor with intact membranes, intraamniotic infection is the most frequent cause of prematurity and is associated with a higher prevalence of maternal and neonatal problems.“\n\nMaternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor.\n\nHannah, M. E., Ohlsson, A., Wang, E. E., Matlow, A., Foster, G. A., Willan, A. R., Hodnett, E. D., Weston, J. A., Farine, D., & Seaward, P. G. (1997). TermPROM Study Group. American journal of obstetrics and gynecology, 177(4), 780–785. https://doi.org/10.1016/s0002-9378(97)70268-0\n\n​Group B streptococcal colonization and preterm labour. (abstract)\n\nMcDonald H, Vigneswaran R, O’Loughlin JA. Aust N Z J Obstet Gynaecol. 1989 Aug;29(3 Pt 2):291-3.\n\nAntibiotic Elimination of Group-B Streptococci in Urine in Prevention of Preterm Labour (abstract)\n\nAC Thomsen, L Morup, KB Hansen. The Lancet, 1(8533):591-593, 1987.\n\nTransmission of Group B Streptococcus in late-onset neonatal disease: a narrative review of current evidence.\n\nMiselli F, Frabboni I, Di Martino M, et al. Therapeutic Advances in Infectious Disease. 2022;9. doi:10.1177/20499361221142732\n\nClinical Risk Factors Associated with Late-Onset Invasive Group B Streptococcal Disease: Systematic Review and Meta-analyses\n\nKarampatsas K, Davies H, Mynarek M, Andrews N, Heath PT, Le Doare K. Clin Infect Dis. 2022 Mar 11:ciac206. doi: 10.1093/cid/ciac206. Epub ahead of print. PMID: 35275986.\n\nUnderstanding Factors in Group B Streptococcus Late-Onset Disease. Infection and drug resistance\n\nBerardi, A., Trevisani, V., Di Caprio, A., Bua, J., China, M., Perrone, B., Pagano, R., Lucaccioni, L., Fanaro, S., Iughetti, L., Lugli, L., & Creti, R. (2021), 14, 3207–3218. https://doi.org/10.2147/IDR.S291511\n\n​​Is It Just Water Under the Bridge? An Eight-Day-Old With Late-Onset Group B Streptococcal Infection After Water Birth\n\nSolt, S. A., Smith, R. L., Pirzadeh, A., Belhorn, T., & Zwemer, E. (2020). Cureus, 12(6), e8614. https://doi.org/10.7759/cureus.8614\n\n​Group B streptococcus late-onset disease, contaminated breast milk and mothers persistently GBS negative: report of 3 cases\n\nNicolini, G., Borellini, M., Loizzo, V., Creti, R., Memo, L., & Berardi, A. (2018). BMC pediatrics, 18(1), 214. https://doi.org/10.1186/s12887-018-1192-x\n\nThe Many Faces of Late Onset Group B Streptococcus Infection. J Pediatric Infection\n\nDudek CJ, Shah C, Zayas J, et al. Dis. 2016, 1:2. doi: 10.21767/2573-0282.100014\n\n​\n\nLate-onset neonatal group B streptococcal disease associated with breast milk transmission: molecular typing using RAPD-PCR.\n\nBrandolini M., Corbella M., Cambieri P., et al. Early Hum Dev. 2014 Mar; 90 Suppl 1:S84-6.\n\nMothers a common source of infection in late-onset GBS\n\nMorven S. Edwards, MD. February 2013. Infectious Disease in Children.\n\nGroup B Streptococcus Late-Onset Disease: 2003–2010 (Full Article)\n\nAlberto Berardi, MD,a Cecilia Rossi, MD,a Licia Lugli, MD,a Roberta Creti, PhD,b et. all, American Academy of Pediatrics Vol. 131 No. 2 February 1, 2013 pp. e361 -e368 (doi: 10.1542/peds.2012-1231)\n\nHorizontal transmission of group B streptococcus in a neonatal intensive care unit.\n\nMorinis J., Shah J., Murthy P., et al. Paediatr Child Health. 2011 Jun-Jul; 16(6): e48-e50.\n\nLate and ultra late onset Streptococcus B meningitis: clinical and bacteriological data over 6 years in France. (abstract)\n\nGuilbert J et al. Acta Paediatr. 2010 Jan;99(1):47-51. doi: 10.1111/j.1651-2227.2009.01510.x.\n\n“These data suggest that LOD and ULOD would be the same clinical and bacteriological entity, except for prematurity, which seems significantly associated with ULOD.”\n\n​Late-onset group B streptococcal disease by infected mother’s milk detected by polymerase chain reaction. (abstract) (.pdf version)\n\nLanari M, Serra L, Cavrini F, Liguori G, Sambri V.,Department of Paediatrics, Santa Maria della Scaletta Hospital, Imola, Italy. New Microbiol. 2007 Jul;30(3):253-4.\n\nNeurodevelopmental Outcome after Culture-Proven or So-Called Culture-Negative Sepsis in Preterm Infants\n\nBedetti L, Corso L, Miselli F, Guidotti I, Toffoli C, Miglio R, Roversi MF, Muttini EdC, Pugliese M, Bertoncelli N, et al. Journal of Clinical Medicine. 2024; 13(4):1140. https://doi.org/10.3390/jcm13041140\n\nMortality and neurodevelopmental outcome after invasive group B streptococcal infection in infants\n\nMaren Mynarek, Torstein Vik, Guro L. Andersen, Anne K.Brigtsen, Sandra Julsen Hollung, Tricia L. Larose, Stian Lydersen, Lene C.Olsen, Marianne S. Strøm, Jan E. Afset, Developmental Medicine & Child Neurology, June 2023.\n\nLong-term Risk of Epilepsy Following Invasive Group B Streptococcus Disease in Neonates in Denmark\n\nLykke MR, Sørensen HT, Lawn JE, Horváth-Puhó E. JAMA Netw Open. 2023;6(4):e239507. doi:10.1001/jamanetworkopen.2023.9507\n\nIncidence of invasive Group B Streptococcal infection and the risk of infant death and cerebral palsy: a Norwegian Cohort Study.\n\nMynarek M, Bjellmo S, Lydersen S, Afset JE, Andersen GL, Vik T. Pediatr Res. 2021 May;89(6):1541-1548. doi: 10.1038/s41390-020-1092-2. Epub 2020 Jul 29. Erratum in: Pediatr Res. 2022 Aug;92(2):612. doi: 10.1038/s41390-021-01887-8. PMID: 32726797; PMCID: PMC8660635.\n\n​Group B Streptococcal Infection in Extremely Preterm Neonates and Neurodevelopmental Outcomes at 2 Years\n\nKaren M Puopolo, MD, PhD, Sagori Mukhopadhyay, MD, MMSc, Nellie I Hansen, MPH, Dustin D Flannery, DO, MSCE, Rachel G Greenberg, MD, MB, MHS, Pablo J Sanchez, MD, Edward F Bell, MD, Sara B DeMauro, MD, MSCE, Myra H Wyckoff, MD, Eric C Eichenwald, MD, Barbara J Stoll, MD, Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network, Clinical Infectious Diseases, 2022;, ciac222, https://doi.org/10.1093/cid/ciac222\n\n​Neurodevelopmental and growth outcomes after invasive Group B Streptococcus in early infancy: A multi-country matched cohort study in South Africa, Mozambique, India, Kenya, and Argentina\n\nP Paul, J Chandna, SR Procter, et al. EClinicalMedicine (2022). published online April 28. https://doi.org/10.1016/j.eclinm.2022.101358\n\nEvery Country, Every Family: Group B Streptococcal Disease Worldwide\n\nVolume 74, Issue Supplement_1, 15 January 2022\n\nInfectious Disorders, Adrenal Glands. Diagnostic Pathology: Endocrine.\n\nNosé V. 2018:414–7. doi: 10.1016/B978-0-323-52480-3.50079-2. Epub 2020 Aug 28. PMCID: PMC7455170.\n\nNeurodevelopmental Impairment in Children After Group B Streptococcal Disease Worldwide: Systematic Review and Meta-analyses\n\nMaya Kohli-Lynch, Neal J Russell, Anna C Seale, Ziyaad Dangor, Cally J Tann, Carol J Baker, et al., Clinical Infectious Diseases, Volume 65, Issue suppl_2, 15 November 2017, Pages S190–S199, https://doi.org/10.1093/cid/cix663\n\nAcute suppurative thyroiditis caused by Streptococcus agalactiae infection: a case report\n\nAkuzawa N, Yokota T, Suzuki T, Kurabayashi M. Clin Case Rep. 2017 Jun 19;5(8):1238-1242. doi: 10.1002/ccr3.1048. PMID: 28781832; PMCID: PMC5538065.\n\nA sexually dichotomous, autistic-like phenotype is induced by Group B Streptococcus maternofetal immune activation.\n\nAllard MJ, Bergeron JD, Baharnoori M, et al. Autism Res. 2016 May 25.\n\nLong-term outcomes of group B streptococcal meningitis.\n\nLibster R., Edwards KM., Levent F., et al. Pediatrics. 2012 Jul; 130(1): e8-15.\n\nDIABETES INSIPIDUS AS A COMPLICATION OF NEONATAL GROUP B STREPTOCOCCAL MENINGITIS.\n\nMacGilvray, Scott S. M.D.; Billow, Michael D.O. The Pediatric Infectious Disease Journal 9(10):p 742, October 1990. ​​\n\nThe success of vaginal birth by use of trans-labial ultrasound plus vaginal examination and vaginal examination only in pregnant women with labor induction: a comparative study.\n\nNouri-Khasheh-Heiran, E., Montazeri, A., Conversano, F. et al. BMC Pregnancy Childbirth 23, 3 (2023). https://doi.org/10.1186/s12884-022-05324-4\n\nCervical Exam at the End of Pregnancy: Learn what the exam can (and cannot) tell you about impending labor\n\nBy Robin Elise Weiss, PhD, MPH. Updated on June 14, 2021. VeryWell Family. Medically reviewed by Rachel Gurevich, RN\n\n​\n\nThe correlation between the number of vaginal examinations during active labor and febrile morbidity, a retrospective cohort study\n\nGluck O, et al. BMC Pregnancy and Childbirth. , Volume 20, Article number: 246 (2020).\n\nThe Myth of the Vaginal Exam\n\nWebsite article at About.com by Robin Elise Weiss, LCCE. (2019)\n\n“Vaginal exams can increase the risks of infection, even when done carefully and with sterile gloves, etc. It pushes the normal bacteria found in the vagina upwards towards the cervix. There is also increased risk of rupturing the membranes.”\n\nIs meconium passage a risk factor for maternal infection in term pregnancies? (abstract)\n\nJazayeri A, Jazayeri MK, Sahinler M, Sincich T. Obstet Gynecol. 99(4):548-52. 2002.\n\n“Meconium passage increases the risk of postpartum endometritis but not chorioamnionitis. Length of labor, internal monitoring, and number of vaginal exams are risk factors for chorioamnionitis.“\n\nCervical Manipulations Linked to Perinatal Sepsis: Consider GBS-specific Chemoprophylaxis (Eight Case Reports)\n\nKathryn DeMott. OB/GYN News, Oct 15, 2001.\n\n“Obstetricians may want to reconsider doing elective cervical manipulation, at least on patients who have cervical vaginal infection or colonization with potential perinatal pathogens. They may also want to consider providing GBS-specific chemoprophylaxis before membrane stripping.”\n\n​\n\nThe microbiologic effect of digital cervical examination. (abstract)\n\nImseis HM, Trout WC, Gabbe SG. Am J Obstet Gynecol. 180(3 Pt 1):578-80. 1999.\n\n“An immediate effect of digital examination is the introduction of vaginal organisms into the cervical canal.“\n\n​Pathophysiology, diagnosis, and management of intraamniotic infection. (abstract)\n\nRiggs JW, Blanco JD. Semin Perinatol. 22(4):251-9. 1998.\n\n“There is no clearly established means for the prevention of IAI, but cervical examinations and cervical manipulation can increase the risk, so caution with their use is still warranted.”\n\nInternational Multicentre Term Prelabor Rupture of Membranes Study: evaluation of predictors of clinical chorioamnionitis and postpartum fever in patients with prelabor rupture of membranes at term. (abstract)\n\nSeaward PG, Hannah ME, Myhr TL, Farine D, Ohlsson A, Wang EE, Haque K, Weston JA, Hewson SA, Ohel G, Hodnett ED. Am J Obstet Gynecol. 177(5):1024-9. 1997.\n\n“Increasing numbers of digital vaginal examinations, longer duration of active labor, and meconium staining of the amniotic fluid were the most important risk factors for the development of clinical chorioamnionitis in women with prelabor rupture of membranes at term.“\n\nCharacterization and control of intraamniotic infection in an urban teaching hospital. (abstract)\n\nSoper DE, Mayhall CG, Froggatt JW. Am J Obstet Gynecol. 175(2):304-9; discussion 309-10. 1996.\n\n“Risk factors (duration of ruptured membranes, use of internal monitoring, number of vaginal examinations) were similar in both term and preterm women with intraamniotic infection.”\n\nAn In-Depth Look at Internal Fetal Monitoring\n\nBy Robin Elise Weiss, PhD, MPH. Updated on June 14, 2021\n\nIs meconium passage a risk factor for maternal infection in term pregnancies? (abstract)\n\nJazayeri A, Jazayeri MK, Sahinler M, Sincich T. Obstet Gynecol. 99(4):548-52. 2002.\n\n“Meconium passage increases the risk of postpartum endometritis but not chorioamnionitis. Length of labor, internal monitoring, and number of vaginal exams are risk factors for chorioamnionitis.”\n\nCharacterization and control of intraamniotic infection in an urban teaching hospital.\n\nSoper, D. E., Mayhall, C. G., & Froggatt, J. W. (1996). American journal of obstetrics and gynecology, 175(2), 304–310. https://doi.org/10.1016/s0002-9378(96)70139-4\n\n​Previous intra-amniotic infection as a risk factor for subsequent peripartal uterine infections. (abstract)\n\nDinsmoor MJ, Gibbs RS.\n\nObstet Gynecol. 74(3 Pt 1):299-301. 1989. “Those patients who did develop recurrent intra-amniotic infection had significantly longer labors, duration of ruptured membranes, and duration of internal monitoring, and an increased number of vaginal examinations.“\n\nRisk factors for intraamniotic infection: a prospective epidemiologic study. (abstract)\n\nSoper DE, Mayhall CG, Dalton HP. Am J Obstet Gynecol. 161(3):562-6; discussion 566-8. 1989.\n\n“The clinical diagnosis of intraamniotic infection was made in (10.5%) patients. Patients with intraamniotic infection were younger, of lower gravidity and parity, more likely to require oxytocin augmentation, and more likely to be monitored internally than were patients who were not infected. They also had longer durations of labor, ruptured membranes, and hospitalization before delivery, had significantly more vaginal examinations, and were more likely to be delivered of infants by cesarean section, as compared with patients without infection. Logistic regression analysis identified four variables independently associated with intraamniotic infection: the number of vaginal examinations, duration of ruptured membranes, use of internal monitors, and duration of total labor.“\n\n​\n\nLogistic regression analysis of risk factors for intra-amniotic infection. (abstract)\n\nNewton ER, Prihoda TJ, Gibbs RS. Obstet Gynecol. 1989 Apr;73(4):571-5.\n\n“…among patients meeting risk criteria, parity, duration of internal monitoring, and duration of membrane rupture were the significant risk factors for intra-amniotic infection.“\n\nNew evidence indicates early induction of labour may reduce inequalities in pregnancy outcomes\n\n21 July 2023 | London School of Hygiene and Tropical Medicine\n\nThe success of vaginal birth by use of trans-labial ultrasound plus vaginal examination and vaginal examination only in pregnant women with labor induction: a comparative study.\n\nNouri-Khasheh-Heiran, E., Montazeri, A., Conversano, F. et al. BMC Pregnancy Childbirth23, 3 (2023). https://doi.org/10.1186/s12884-022-05324-4\n\nMaternal Colonization With Group B Streptococcus and the Risk for Infection After Cervical Ripening With a Transcervical Foley Catheter\n\nBen-David, A., Meyer, R., Regev, N., & Mazaki-Tovi, S. (2021). Obstetrics and gynecology, 137(4), 662–663. https://doi.org/10.1097/AOG.0000000000004306\n\n​The impact of induction of labor at 39 weeks in low-risk women on the incidence of stillbirth\n\nPo' G, Oliver EA, Reddy UM, Silver RM, Berghella V. Am J Obstet Gynecol. 2020 Jan;222(1):88-90. doi: 10.1016/j.ajog.2019.09.032. Epub 2019 Sep 20. PMID: 31545942.\n\nMembrane Sweeping in Group B Streptococcus (GBS) Positive Patients​\n\nJennifer Keller, George Washington University. February 15, 2013\n\n​Methods of induction of labour: a systematic review. (abstract)\n\nMozurkewich EL, Chilimigras JL, Berman DR, Perni UC, Romero VC, King VJ, Keeton KL.\n\nBMC Pregnancy Childbirth. 2011 Oct 27;11:84. doi: 10.1186/1471-2393-11-84.\n\n​Maternal colonization with Group B Streptococcus and prelabor rupture of membranes at term: The role of induction in labor. (abstract)\n\nHannah, Mary E. MD,CM, et. al. Am J Obstet Gynecol. 177:780-785. 1997.\n\n“RESULTS: Group B streptococci were predictive of neonatal infection for the induction with vaginal prostaglandin E2 gel and expectant groups but not for the induction with oxytocin group. For women positive for group B streptococci the rates of neonatal infection were 2.5% for the induction with oxytocin group and > 8% for all other groups. CONCLUSIONS: Induction of labor with intravenous oxytocin may be preferable for group B streptococci-positive women with prelabor rupture of membranes at term.”\n\nThe Historical Practice of “Membrane Sweep” to Initiate Labour: Does it Have a Role in Contemporary Obstetric Practice?​\n\nSukumaran S, Chandraharan E. Glob J Reprod Med. 2021; 8(2): 5556733.\n\n​​\n\nMembrane sweeping for induction of labourFinucane EM, Murphy DJ, Biesty LM, Gyte GML, Cotter AM, Ryan EM, Boulvain M, Devane D (2020). Cochrane.\n\nMembrane Sweeping in Group B Streptococcus (GBS) Positive Patients​\n\nJennifer Keller, George Washington University. February 15, 2013\n\n​Cervical Manipulations Linked to Perinatal Sepsis: Consider GBS-specific Chemoprophylaxis (Eight Case Reports)\n\nKathryn DeMott. OB/GYN News, Oct 15, 2001.\n\n“Obstetricians may want to reconsider doing elective cervical manipulation, at least on patients who have cervical vaginal infection or colonization with potential perinatal pathogens. They may also want to consider providing GBS-specific chemoprophylaxis before membrane stripping.”\n\n​Group B Streptococcus.(abstract)\n\nAnne Schuchat MD. The Lancet; 353: 51-6. 1999\n\n“Birth practices differ substantially around the world, and home births and less invasive procedures during hospital births might limit the risk of GBS sepsis in the newborn.”\n\nMaternal colonization with Group B Streptococcus and prelabor rupture of membranes at term: The role of induction in labor. (abstract)\n\nHannah, Mary E. MD,CM, et. al. Am J Obstet Gynecol. 177:780-785. 1997.\n\n“RESULTS: Group B streptococci were predictive of neonatal infection for the induction with vaginal prostaglandin E2 gel and expectant groups but not for the induction with oxytocin group. For women positive for group B streptococci the rates of neonatal infection were 2.5% for the induction with oxytocin group and > 8% for all other groups. CONCLUSIONS: Induction of labor with intravenous oxytocin may be preferable for group B streptococci-positive women with prelabor rupture of membranes at term.”\n\nGroup B Strep: A Patient/Provider Approach for Optimizing Care\n\nJames McGregor, MDCM “Research has been done showing that both labor contractions and manual or digital examinations by care providers can actually move infectious vaginal fluid through the mouth of the womb.”\n\nVaginal microbial dynamics and pathogen colonization in a humanized microbiota mouse model\n\nMejia, M.E., Mercado-Evans, V., Zulk, J.J. et al. npj Biofilms Microbiomes 9, 87 (2023). https://doi.org/10.1038/s41522-023-00454-9\n\nCompositional Changes in the Vaginal Bacterial Microbiome of Healthy Pregnant Women across the Three Gestational Trimesters in Ismailia, Egypt\n\nMariam E. Amin, Marwa Azab, Amro Hanora, Khaled Atwa, Sarah Shabayek. Microorganisms 2023, 11(1), 139.\n\n​\n\nAssociation between maternal antibiotic exposure and collateral effects related to microbiome changes in young children: A systematic review (poster)\n\nRita W.Y. Ng, Dulmini Nanayakkara Sapugahawatte, Priyanga Dharmaratne, Margaret Ip. Conference: Microbiome Interactions in Health and Disease (24–26 October 2022 Wellcome Genome Campus, UK)\n\n​Alterations of the vaginal microbiome in healthy pregnant women positive for group B Streptococcus colonization during the third trimester.\n\nShabayek, S., Abdellah, A. M., Salah, M., Ramadan, M., & Fahmy, N. (2022). BMC microbiology, 22(1), 313. https://doi.org/10.1186/s12866-022-02730-8\n\nGardnerella vaginalis promotes group B Streptococcus vaginal colonization, enabling ascending uteroplacental infection in pregnant mice\n\nGilbert, N. M., Foster, L. R., Cao, B., Yin, Y., Mysorekar, I. U., & Lewis, A. L. (2021). American journal of obstetrics and gynecology, 224(5), 530.e1–530.e17. https://doi.org/10.1016/j.ajog.2020.11.032\n\nFertility factors affect the vaginal microbiome in women of reproductive age.\n\nXu, J., Bian, G., Zheng, M., Lu, G., Chan, W. Y., Li, W., Yang, K., Chen, Z. J., & Du, Y. (2020). American journal of reproductive immunology (New York, N.Y. : 1989), 83(4), e13220. https://doi.org/10.1111/aji.13220\n\nDisturbing the neonatal microbiome is a small price to pay for preventing early-onset neonatal group B streptococcus disease: AGAINST: Against relying on antibiotics to prevent early-onset neonatal group B streptococcus disease\n\nDavid M Aronoff, Martin J Blaser. BJOG 127:2 P229. 06 November 2019 https://doi.org/10.1111/1471-0528.15988\n\nHuman placenta has no microbiome but can contain potential pathogens\n\nMarcus C. de Goffau, et al. (2019) Nature: International Journal of Science\n\nGroup B Streptococcus and the Vaginal Microbiota\n\nRosen, G. H., Randis, T. M., Desai, P. V., Sapra, K. J., Ma, B., Gajer, P., Humphrys, M. S., Ravel, J., Gelber, S. E., & Ratner, A. J. (2017). The Journal of infectious diseases, 216(6), 744–751. https://doi.org/10.1093/infdis/jix395\n\nPenn: Mom's stress alters babies' gut and brain through vaginal microbiome.\n\nUniversity of Pennsylvania. EurekAlert Global Source for Science News. 22 Jun, 2015.\n\nPlacental lesions associated with stillbirth by gestational age, according to feature importance: Results from the stillbirth collaborative research network\n\nTess E.K. Cersonsky,Rose K. Cersonsky,George R. Saade, Robert M. Silver, Uma M. Reddy, Robert L. Goldenberg, Donald J. Dudley, Halit Pinar. Placenta, Volume 137, June 2023, Pages 59-64.\n\nHuman placenta has no microbiome but can contain potential pathogens\n\nMarcus C. de Goffau, et al. (2019) Nature: International Journal of Science\n\n​Notes from the Field: Late-Onset Infant Group B Streptococcus Infection Associated with Maternal Consumption of Capsultes Containing Dehydrated Placenta\n\n​Buser GL, Mató S, Zhang AY, Metcalf BJ, Beall B, Thomas AR. Notes from the Field: Late-Onset Infant Group B Streptococcus Infection Associated with Maternal Consumption of Capsules Containing Dehydrated Placenta — Oregon, 2016. MMWR Morb Mortal Wkly Rep 2017;66:677–678. DOI: http://dx.doi.org/10.15585/mmwr.mm6625a4\n\nThe role of the placenta in feto-neonatal infections. (abstract)\n\nSpinillo A, Iacobone AD, Calvino IG, Alberi I, Gardella B. Early Hum Dev. 2014 Mar;90 Suppl 1:S7-9. doi: 10.1016/S0378-3782(14)70003-9.\n\nThe Placenta Harbors a Unique Microbiome. (abstract)\n\nKjersti Aagaard et al. Sci Transl Med. 21 May 2014: Vol. 6, Issue 237, p. 237ra65 Sci. Transl. Med. DOI: 10.1126/scitranslmed.3008599″>10.1126/scitranslmed.3008599\n\n​\n\nStudy Sees Bigger Role for Placenta in Newborns’ Health\n\nDenise Grady. New York Times, May 21, 2014\n\n“A study led by Dr. Kjersti Aagaard found that the placenta has its own microbiome that may help shape the health of an infant.”\n\nA hemolytic pigment of Group B Streptococcus allows bacterial penetration of human placenta. (abstract and link to full text)\n\nWhidbey C et al. J Exp Med. 2013 Jun 3;210(6):1265-81. doi: 10.1084/jem.20122753. Epub 2013 May 27.\n\nLyme Disease May Be Sexually Transmitted, Study Suggests\n\n​Guinnevere Stevens. PRWEB. Jan. 25, 2014.\n\nThe Regulation of Inflammatory Pathways and Infectious Disease of the Cervix by Seminal Fluid.\n\nAdefuye A, Anthony Katz A, Jason Sales K. Patholog Res Int. 2014; 2014: 748740.\n\nMajor Bactericidal Activity of Human Seminal Plasma Is Zinc-Dependent and Derived from Fragmentation of the Semenogelins\n\nAnneli M. L. Edström et al. J Immunol. 2008 September 1; 181(5): 3413–3421.\n\n​Risk Factors for Group B Streptococcal Colonization: Potential for Different Transmission Systems by Capsular Type.\n\nB. Foxman, B. W. Gillespie, S. D. Manning, et al. Ann Epidemiol. 2007 Nov; 17(11): 854–862.\n\nIncidence and Duration of Group B Streptococcus by Serotype among Male and Female College Students Living in a Singe Dormitory.\n\nFoxman B., Gillespie B., Manning S. D., et al. Am J Epidemiol (2006) 163 (6): 544-551.\n\nPrevalence of group B streptococcus colonization and potential for transmission by casual contact in healthy young men and women. (abstract)\n\nManning SD, Neighbors K, Tallman PA, Gillespie B, Marrs CF, Borchardt SM, Baker CJ, Pearlman MD, Foxman B.\n\nClin Infect Dis. 2004 Aug 1;39(3):380-8. Epub 2004 Jul 16.\n\nAssociation of sexual activity with colonization and vaginal acquisition of group B Streptococcus in nonpregnant women. (abstract)\n\nMeyn LA, Moore DM, Hillier SL, Krohn MA. Am J Epidemiol. 2002 May 15;155(10):949-57.\n\nDeterminants of co-colonization with group B streptococcus among heterosexual college couples.\n\nManning SD, Tallman P, Baker CJ, Gillespie B, Marrs CF, Foxman B. Epidemiology. 2002 Sep;13(5):533-9.\n\n“Among heterosexual college couples, sexual activity, particularly male-to-female oral sex, increases the risk of co-colonization with an identical group B strain. Future studies should evaluate the role of the pharynx and examine the effects of both bacterial characteristics and host response on transmission.”\n\nGroup B Streptococcus Colonization in Male and Nonpregnant Female University Students: A Cross-Sectional Prevalence Study.\n\nSandra J. Bliss et al. Clin Infect Dis. (2002) 34 (2):184-190.doi: 10.1086/338258\n\n​Sexual transmission and reinfection of group B streptococci between spouses.\n\nYamamoto T, Nagasawa I, Nojima M, Yoshida K, Kuwabara Y. J Obstet Gynaecol Res. 1999 Jun;25(3):215-9.\n\nSexual behavior and vaginal colonization by group B streptococcus among minority women. (abstract)\n\nNewton ER., Butler MC., Shain RN. Obstet Gynecol. 1996 Oct; 88(4 Pt 1) 577-82.\n\nPharyngeal flora in a sexually active population.\n\nRussell JM., Azadian BS., Roberts AP., et al. Int J STD AIDS. 1995 may-Jun; 6(3): 211-5.\n\nAsymptomatic pharyngeal carriage of beta-haemolytic streptococci and streptococcal pharyngitis among patients at an urban hospital in Croatia.\n\nBegovac J., Bobinac E., Benic B., et al. Eur J Epidemol. 1993 Jul; 9(4): 405-10.\n\nAntimicrobial activity of human seminal fluid. (abstract)\n\nMårdh PA, Colleen S. Scand J Urol Nephrol. 1975;9(1):17-23.\n\nPreventing and Addressing Stillbirths Along the Continuum of Care: A Global Advocacy and Implementation Guide\n\n\"This action-focused guide brings together existing resources and practical guidance to inform planning, investments and programmes aimed at ending preventable stillbirths and improving care for all women and families who experience stillbirth. It also highlights case studies from a wide range of contexts to showcase what can be achieved.”\n\nPlacental lesions associated with stillbirth by gestational age, according to feature importance: Results from the stillbirth collaborative research network\n\nTess E.K. Cersonsky, Rose K. Cersonsky, George R. Saade, Robert M. Silver, Uma M. Reddy, Robert L. Goldenberg, Donald J. Dudley, Halit Pinar. Placenta, Volume 137, June 2023, Pages 59-64.\n\nStillbirths in Cameroon: an analysis of the 1998–2011 demographic and health surveys\n\nAmani, A., Nansseu, J.R., Ndeffo, G.F. et al.. BMC Pregnancy Childbirth 22, 736 (2022). https://doi.org/10.1186/s12884-022-04993-5\n\nMicrobial Analysis of Umbilical Cord Blood Reveals Novel Pathogens Associated with Stillbirth and Early Preterm Birth.\n\nVander Haar, E. L., Wu, G., Gyamfi-Bannerman, C., Thomas, C., Wapner, R. J., Reddy, U. M., Zhao, L., Silver, R. M., Goldenberg, R. L., & Han, Y. W. (2022). mBio, 13(5), e0203622. https://doi.org/10.1128/mbio.02036-22\n\n\"Too much, too late\": data on stillbirths to improve interpretation of caesarean section rates\n\nZethof S, Christou A, Benova L, van Roosmalen J, van den Akker T. Bull World Health Organ. 2022 Apr 1;100(4):289-291. doi: 10.2471/BLT.21.287539. Epub 2022 Feb 28. PMID: 35386563; PMCID: PMC8958836.\n\nStillbirth prevention and respectful bereavement care\n\n24 August 2021. Cochrane Special Collections\n\nEstimation of pregnancy losses attributable to exposure to ambient fine particles in south Asia: an epidemiological case-control study\n\nTao Xue, Tianjia Guan, Guannan Geng, Qiang Zhang, Yong Zhao, Tong Zhu. The Lancet. VOLUME 5, ISSUE 1, E15-E24, JANUARY 01, 2021. DOI: https://doi.org/10.1016/S2542-5196(20)30268-0\n\n​A Neglected Tragedy: The global burden of stillbirths\n\nOctober 2020\n\nThe impact of induction of labor at 39 weeks in low-risk women on the incidence of stillbirth\n\nPo' G, Oliver EA, Reddy UM, Silver RM, Berghella V. Am J Obstet Gynecol. 2020 Jan;222(1):88-90. doi: 10.1016/j.ajog.2019.09.032. Epub 2019 Sep 20. PMID: 31545942.\n\n2.6 MILLION REASONS TO INVEST IN STILLBIRTH ESTIMATES\n\nAuthors: Hannah Blencowe, London School of Hygiene & Tropical Medicine, and Susannah Leisher, International Stillbirth Alliance on behalf of the Stillbirth Advocacy Working Group (SAWG), founded by World Health Organization’s Partnership for Maternal, Newborn and Child Health. (Feb 2018)\n\n​\n\nHow The Lancet mobilized scientists to tackle a silent scandal\n\nHighlighting the data behind stillbirths to bring about change\n\nRosanna Armstrong - January 24, 2018\n\nStillbirth Rates Rise After 39-Week Rule\n\nCaroline Helwick. Medscape Pediatrics. February 05, 2016.\n\nFetal Death: 'Unspecified' Tops List of Causes\n\n​Molly Walker. MedPage Today. 2016 Nov. 02.\n\nPicturing health: stories of stillbirths.\n\nMatthieu Zellweger. The Lancet. Volume 388, No. 10060, p2588-2599, 26 Nov 2016.\n\nReductions in stillbirths—more than a triple return on investment\n\n​Hoope-Bender P., Stenberg k., Sweeny K. World Health Organization. Volume 387, No. 10018, e14-e16, 6 Feb 2016.\n\nTriple return on investment:the cost and impact of 13 interventions that could prevent stillbirths and save the lives of mothers and babies in South Africa\n\n​Michalow J., Chola L., McGee S., et al. BMC Pregnancy and Childbirth. 2015 Feb. 18. 15:39.\n\nSilent loss and the clinical encounter: Parents’ and physicians’ experiences of stillbirth–a qualitative analysis.\n\n​Maureen C Kelley and Susan B Trinidad.\n\nBioMed Central Pregnancy and Childbirth. 2012 12:137.\n\nProceedings of the Stillbirth Summit 2011\n\nGBSI attended this eye-opening conference on the many causes of stillbirth. Dr. James A. McGregor’s presentation on “Infection and Inflammation” is included as well as presentations by top stillbirth researchers around the world.\n\nInfectious Causes of Stillbirth: A Clinical Perspective.\n\nMcClure EM., Dudley DJ., Reddy U., et al. Clin Obstet Gynecol. 2010 Sep; 53(3): 635-645.\n\nThe Challenge of Fetal Mortality\n\nMacDorman M, Kirmeyer S. The challenge of fetal mortality. NCHS data brief, no 16. Hyattsville, MD: National Center for Health Statistics. 2009.\n\n​\n\nPrediction and prevention of recurrent stillbirth (abstract)\n\nUM Reddy. Obstet Gynecol. 110(5):1151-64, November 2007.\n\nThe infectious origins of stillbirth\n\nGoldenberg RL, Thompson C. Am J Obstet Gynecol. 2003 Sep;189(3):861-73. doi: 10.1067/s0002-9378(03)00470-8. PMID: 14526331.\n\nThe Fungal Pathogen Candida albicans Promotes Bladder Colonization of Group B Streptococcus\n\nShing Samuel R., Ramos Anissa R., Patras Kathryn A., Riestra Angelica M., McCabe Sinead, Nizet Victor, Coady Alison. Frontiers in Cellular and Infection Microbiology. 9, 2020. 10.3389/fcimb.2019.00437\n\nGroup B Streptococcal Bacteriuria in Pregnancy: An Evidence-Based, Patient-Centered Approach to Care\n\nSchafer R, Phillippi JC. J Midwifery Womens Health. 2020 May;65(3):376-381. doi: 10.1111/jmwh.13085. Epub 2020 Feb 25. PMID: 32096338.\n\nClinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of America.\n\nNicolle LE, Gupta K, Bradley SF, et al. Clin Infect Dis. 2019;68(10):e83‐e110. doi:10.1093/cid/ciy1121\n\nAsymptomatic Bacteriuria in Adults: Screening.\n\nUS. Preventive Services Task Force. Sept. 24, 2019.\n\n​\n\nNo. 276-Management of Group B Streptococcal Bacteriuria in Pregnancy\n\nAllen VM, Yudin MH. J Obstet Gynaecol Can. 2018 Feb;40(2):e181-e186. doi: 10.1016/j.jogc.2017.11.025. PMID: 29447722.\n\n​Preterm Birth Associated With Group B Streptococcus Maternal Colonization Worldwide: Systematic Review and Meta-analyses.\n\nBianchi-Jassir F, Seale AC, et al. Clin Infect Dis. 2017 Nov 6;65(suppl_2):S133-S142. doi: 10.1093/cid/cix661.\n\n\"From this review, there is evidence to suggest that preterm birth is associated with maternal GBS colonization, especially where there is evidence of ascending infection (bacteriuria).\"\n\n​Antibiotics for asymptomatic bacteriuria in pregnancy.\n\nSmaill FM, Vazquez JC. Cochrane Database Syst Rev. 2015;(8):CD000490. Published 2015 Aug 7. doi:10.1002/14651858.CD000490.pub3\n\nAsymptomatic bacteriuria & obstetric outcome following treatment in early versus late pregnancy in north Indian women.\n\nJain, V., Das, V., Agarwal, A., & Pandey, A. (2013). The Indian journal of medical research, 137(4), 753–758.\n\nBacteruria with group-B streptococcus: is it a risk factor for adverse pregnancy outcomes?\n\nKessous, R., Weintraub, A. Y., Sergienko, R., Lazer, T., Press, F., Wiznitzer, A., & Sheiner, E. (2012). The Journal of Maternal-Fetal & Neonatal Medicine, 25(10), 1983–1986. https://doi.org/10.3109/14767058.2012.671872\n\nPrevention of Group B Streptococcal Disease in the Newborn\n\nBS Apgar, MD, MS; G Greenberg, MD, MA; and G YEN, MD. American Family Physician, March 1 2005\n\n“Compared with infants born to lightly colonized women, those born to heavily colonized women have 2.5 times the risk of infection. Neonates born to mothers who have GBS bacteriuria at any time during pregnancy are known to be more frequently and more heavily colonized with GBS and are more likely to develop sepsis. Infections that occur in the first two days of life usually are caused by exposure to maternal organisms. Risk factors for neonatal transmission and infection are listed in Table 1. Compared with term newborns, preterm and low-birth-weight infants have increased rates of GBS sepsis.”\n\nAntibiotic Elimination of Group-B Streptococci in Urine in Prevention of Preterm Labour (abstract)\n\nAC Thomsen, L Morup, KB Hansen. The Lancet, 1(8533):591-593, 1987.\n\nAsymptomatic bacteriuria during pregnancy with special reference to group B streptococci\n\nPersson K, Christensen KK, Christensen P, Forsgren A, Jörgensen C, Persson PH. Scand J Infect Dis. 1985;17(2):195‐199. doi:10.3109/inf.1985.17.issue-2.11\n\n​Smartphone, M.D.: App IDs Bacteria in Just One Hour\n\nIn a potential game changer for the healthcare industry, a new cell phone app and lab kit now allow a smartphone to identify bacteria from patients anywhere in the world."
    }
}